The global Hyaluronic Acid Raw Material Market size is
expected to reach a value of USD 7.25 billion by 2024, according to a new
report by Grand View Research, Inc. The increasing use of hyaluronic acid in
various medical applications, such as osteoarthritis, wound healing,
postoperative adhesion, tympanic membrane repair, tumor diagnosis, fracture
healing, and soft tissue repair is expected to fuel the market growth over the
forecast period.
The orthopedics segment dominated the overall market
in 2015 with the highest revenue generation. The increasing geriatric
population base, rising incidence of osteoarthritis, and growing adoption of
viscosupplements in the treatments contribute to the large market share of this
segment. Furthermore, the drug delivery segment is projected to be the fastest
growing over the forecast period with a significantly higher CAGR. The
increasing R&D activities focusing on targeted drug delivery systems and
growing usage of hyaluronic acid in anti-cancer drug delivery is expected to
contribute to the market growth.
The increasing women population of age 35 to 65
years across the globe engenders a greater demand for anti-aging cosmetic and
aesthetic treatments. Owing to the distinctive viscoelastic and moisturizing
properties coupled with lower toxicity levels offered by hyaluronic acid-based
products, the demand for this polymer in dermal fillers as well as in the
treatment of vesicoureteral reflux is expected to experience growth. Thus, it
is anticipated that the need for such products will serve as a high impact
driver for the hyaluronic acid products over the forecast period. Based on the
statistics of the International Society of Aesthetic Plastic Surgery in 2014,
there were approximately 20 million cosmetic procedures performed globally, of
which nearly 13.5% of the procedures were HA-based non-surgical procedures.
Some of the top countries recording a majority of
the aesthetic treatments in 2014 were the U.S., Brazil, Japan, South Korea,
Mexico, Germany, France, and Colombia. Medical tourism for cosmetic surgery in
the U.S. plays a very important role in aiding the uptake of HA-based products
and procedures, which is expected to drive the market in the coming few years.
Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/hyaluronic-acid-ha-raw-material-market
Further Key Findings From the Study Suggest:
- In 2015, orthopedics was the largest
application segment, owing to rising prevalence and incidence of
osteoarthritis
- The introduction of FDA-approved
hyaluronic acid-based viscosupplements such as ORTHOVISC and MONOVISC is
expected to boost usage over the next 8 years
- Some of the key market players are Salix
Pharmaceuticals; ALLERGAN; Lifecore Biomedical, LLC; Shiseido Co., Ltd.;
Anika Therapeutics, Inc.; Smith & Nephew; Maruha Nichiro Corporation;
Ferring B.V.; SEIKAGAKU CORPORATION; Genzyme Corporation; F. Hoffmann-La
Roche Ltd., Contipro a.s.; Zimmer Biomet; and others
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company, registered
in the State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment